Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein. | Vaccines (Basel) | 2023 | 37243095 | PubTator, text mining | PubMed |
| Vocal Cord Paralysis and Feeding Difficulties as Early Diagnostic Clues of Congenital Myasthenic Syndrome with Neonatal Onset: A Case Report and Review of Literature. | J Pers Med | 2023 | 37240968 | PubTator, text mining | PubMed |
| Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources. | Int J Mol Sci | 2023 | 37240183 | PubTator, text mining | PubMed |
| Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease. | Int J Mol Sci | 2023 | 37239850 | PubTator, text mining | PubMed |
| Evolving Diagnostic and Treatment Strategies for Pediatric CNS Tumors: The Impact of Lipid Metabolism. | Biomedicines | 2023 | 37239036 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis reveals insights into Chinese forest musk deer (Moschus berezovskii) genome evolution and musk synthesis. | Front Cell Dev Biol | 2023 | 37228656 | PubTator, text mining | PubMed |
| Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study. | Front Immunol | 2023 | 37223097 | PubTator, text mining | PubMed |
| Bulbar Onset Amyotrophic Lateral Sclerosis in a COVID-19 Patient: A Case Report. | Cureus | 2023 | 37214058 | PubTator, text mining | PubMed |
| Mortality of myasthenia gravis: a national population-based study in China. | Ann Clin Transl Neurol | 2023 | 37212271 | PubTator, text mining | PubMed |
| Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models. | J Neuromuscul Dis | 2023 | 37212067 | PubTator, text mining | PubMed |
| Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity. | BMC Infect Dis | 2023 | 37198536 | PubTator, text mining | PubMed |
| Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. | Cancers (Basel) | 2023 | 37190191 | PubTator, text mining | PubMed |
| Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders. | J Neuromuscul Dis | 2023 | 37182896 | PubTator, text mining | PubMed |
| Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies. | J Clin Med | 2023 | 37176748 | PubTator, text mining | PubMed |
| A Descriptive Whole-Genome Transcriptomics Study in a Stem Cell-Based Tool Predicts Multiple Tissue-Specific Beneficial Potential and Molecular Targets of Carnosic Acid. | Int J Mol Sci | 2023 | 37175790 | PubTator, text mining | PubMed |
| APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer's Disease. | Int J Mol Sci | 2023 | 37175515 | PubTator, text mining | PubMed |
| The Plasma Cell Infiltrate Populating the Muscle Tissue of Patients with Inclusion Body Myositis Features Distinct B Cell Receptor Repertoire Properties. | Immunohorizons | 2023 | 37171806 | PubTator, text mining | PubMed |
| Pathogenesis of autoimmune disease. | Nat Rev Nephrol | 2023 | 37165096 | PubTator, text mining | PubMed |
| Myasthenia Gravis: Novel Findings and Perspectives on Traditional to Regenerative Therapeutic Interventions. | Aging Dis | 2023 | 37163445 | PubTator, text mining | PubMed |
| Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK. | Sci Rep | 2023 | 37156800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=26